G1 THERAPEUTICS - Stock Price History | GTHX

Historical daily share price chart and data for G1 THERAPEUTICS since 2021 adjusted for splits. The latest closing stock price for G1 THERAPEUTICS as of September 27, 2021 is 15.94.
  • The all-time high G1 THERAPEUTICS stock closing price was 67.97 on September 13, 2018.
  • The G1 THERAPEUTICS 52-week high stock price is 37.07, which is 132.6% above the current share price.
  • The G1 THERAPEUTICS 52-week low stock price is 10.81, which is 32.2% below the current share price.
  • The average G1 THERAPEUTICS stock price for the last 52 weeks is 19.14.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
G1 THERAPEUTICS Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 16.6492 26.3200 26.3200 9.0700 17.9900 -31.93%
2019 23.8000 19.5600 40.5800 14.4000 26.4300 38.02%
2018 40.4970 20.4900 67.9700 16.5100 19.1500 -3.48%
2017 19.4791 15.0000 27.1200 12.5300 19.8400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.675B $0.045B
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company's product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29